Fibrinogen as a hemostatic agent

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 3, 2012, Pages 268-273

  Sørensen, Benny ^a,b,c,d   Larsen, Ole Halfdan ^a,c   Rea, Catherine J ^a,b   Tang, Mariann ^a,c   Foley, Jonathan H ^a,b   Fenger Eriksen, Christian ^a,c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

cardiac surgery; fibrinogen; trauma

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR CONCENTRATE; CYTOCHALASIN D; DABIGATRAN; DEXTRAN; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; FRESH FROZEN PLASMA; GELATIN; HEMOSTATIC AGENT; HETASTARCH; ISOPROTEIN; PLASMA SUBSTITUTE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ALTERNATIVE RNA SPLICING; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CARBOXY TERMINAL SEQUENCE; CARDIOPULMONARY BYPASS; CRYOPRECIPITATE; DIAGNOSTIC PROCEDURES; EXTRACORPOREAL CIRCULATION; FIBRIN POLYMERIZATION; FIBRINOGEN DEFECT; FIBRINOGEN SYNTHESIS; FIBRINOGENOLYSIS; FLUID RESUSCITATION; HEART SURGERY; HUMAN; HYPOFIBRINOGENEMIA; IATROGENIC DISEASE; PERFUSION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TRANSFUSION RELATED ACUTE LUNG INJURY; VIRUS INFECTION; VIRUS TRANSMISSION;

FIBRINOGEN; HEMOSTATICS; HUMANS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84860215865     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1309287     Document Type: Article

References (44)

1. Fenger-Eriksen C, Anker-Mller E, Heslop J, Ingerslev J, Srensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth: 2005; 94 3 324 329 (Pubitemid 40352852)
2. Fries D, Krismer A, Klingler A., et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth: 2005; 95 2 172 177 (Pubitemid 41487140)
3. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem: 2005; 70 247 299 (Pubitemid 40544785)
4. Martini WZ, Chinkes DL, Pusateri AE., et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab: 2005; 289 5 E930 E934 (Pubitemid 41504395)
5. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth: 2010; 105 2 116 121
6. Kozek-Langenecker S, Srensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care: 2011; 15 5 R239
7. O'Shaughnessy DF, Atterbury C, Bolton Maggs P., et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol: 2004; 126 1 11 28 (Pubitemid 38859478)
8. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion: 2006; 46 8 1279 1285 (Pubitemid 44117952)
9. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol: 2004; 125 1 69 73 (Pubitemid 38453280)
10. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol: 2004; 126 1 139 152 (Pubitemid 38859495)
11. Hornsey VS, Young DA, Docherty A, Hughes W, Prowse CV. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration. Transfus Med: 2004; 14 5 369 374 (Pubitemid 39472365)
12. Yazer MH, Triulzi DJ, Hassett AC, Kiss JE. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. Transfusion: 2010; 50 5 1014 1018
13. Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transfus Med Rev: 2009; 23 3 177 188
14. Bevan DH. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? Thromb Res: 2009; 124 02 S12 S16
15. Gröner A. Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion- transmitted infection. Haematologica 2007;92:846-9. Haematologica: 2008; 93 2 e24 e26, author reply e27 (Pubitemid 351397730)
16. Rahe-Meyer N, Solomon C, Winterhalter M., et al. Thromboelastometry- guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg: 2009; 138 3 694 702
17. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma: 2006; 60 6, Suppl S3 S11
18. Dirkmann D, Hanke AA, Görlinger K, Peters J. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg: 2008; 106 6 1627 1632
19. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Srensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth: 2008; 101 6 769 773
20. Karkouti K, Wijeysundera DN, Yau TM., et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion: 2004; 44 10 1453 1462 (Pubitemid 39318980)
21. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations: why a worse outcome? Ann Thorac Surg: 2008; 86 5 1557 1562
22. Solomon C, Rahe-Meyer N, Srensen B. Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res: 2011; 128 3 277 282
23. Tang M., Wierup P, Christiansen K, Greisen J, Sorensen B. Post cardiac coagulopathy; a 48 hours longitudinal descriptive study based on whole blood clot formation and thrombin generation. J Thromb Haemost: 2011; 9 02 51 (Abstract O-MO-126)
24. De Cristofaro R, Landolfi R. Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations. Blood Coagul Fibrinolysis: 1998; 9 3 251 259 (Pubitemid 28255517)
25. Solomon C, Cadamuro J, Ziegler B., et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion: 2011; 51 8 1695 1706
26. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion: 2008; 48 10 2152 2158
27. Rahe-Meyer N, Pichlmaier M, Haverich A., et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth: 2009; 102 6 785 792
28. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Srensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion: 2010; 50 2571 2576
29. Lindahl TL, Baghaei F, Blixter IF., et al. Expert Group on Coagulation of the External Quality Assurance in Laboratory Medicine in Sweden. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays. Thromb Haemost: 2011; 105 2 371 378
30. Arins RA. Elevated fibrinogen causes thrombosis. Blood: 2011; 117 18 4687 4688
31. Danesh J, Lewington S, Thompson SG., et al. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA: 2005; 294 14 1799 1809 (Pubitemid 41434626)
32. Van Hylckama Vlieg A, Callas PW, Cushman M, Bertina RM, Rosendaal FR. Inter-relation of coagulation factors and d-dimer levels in healthy individuals. J Thromb Haemost: 2003; 1 3 516 522
33. Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood: 2011; 117 18 4953 4963
34. Rea CJ, Sorensen B, Ingerslev J, Laursen PN. Fibrinogen: a procoagulant and an anticoagulant. Blood: 2011;; ASH Annual Meeting Abstracts;116:384
35. de Bosch NB, Mosesson MW, Ruiz-Sez A, Echenagucia M, Rodriguez-Lemoin A. Inhibition of thrombin generation in plasma by fibrin formation (antithrombin I). Thromb Haemost: 2002; 88 2 253 258 (Pubitemid 34873706)
36. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med: 2008; 18 3 151 157 (Pubitemid 351847329)
37. Thorarinsdottir HR, Sigurbjornsson FT, Hreinsson K, Onundarson PT, Gudbjartsson T, Sigurdsson GH. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta Anaesthesiol Scand: 2010; 54 9 1077 1082
38. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Srensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth: 2008; 101 6 769 773
39. Dans AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang: 2008; 94 3 221 226 (Pubitemid 351379659)
40. Schöchl H, Nienaber U, Hofer G., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care: 2010; 14 2 R55
41. Stinger HK, Spinella PC, Perkins JG., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma: 2008; 64 2, Suppl S79 S85, discussion S85
42. Karlsson M, Ternström L, Hyllner M., et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost: 2009; 102 1 137 144
43. Fenger-Eriksen C, Jensen TM, Kristensen BS., et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost: 2009; 7 5 795 802
44. Rahe-Meyer N. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. Thromb Res: 2011; 128 01 S17 S19